Aussies zero in on next-gen gene therapy
An Australian biotech has been awarded $2 million to support the development of a next-generation gene therapy candidate for motor neurone disease (MND).
To see the whole article, log in or create an account.
An Australian biotech has been awarded $2 million to support the development of a next-generation gene therapy candidate for motor neurone disease (MND).
To see the whole article, log in or create an account.